Stock report · Delisted · NYSE
Nevro Corp (NVRO)
5.84USD Delisted Final close · Mar 27, 2025
NVRO no longer trades. Nevro was delisted from the NYSE in March 2025.
All prices on this page are historical. The last trade was on March 27, 2025, at $5.84.
NVRO stock price history
Final trading statistics
- Final close
- $5.84
- Final trading day
- Mar 27, 2025
- Market cap at delisting
- $224.09M
- Shares outstanding
- 38.37M
- Final 52-week range
- $3.17 – $14.70
- Avg. volume (final 3 mo.)
- 1,224,648
- All-time high
- $184.34 · Dec 2020
- All-time low
- $3.29 · Jan 2025
- Return since IPO
- -76.8%
- Beta
- 0.82
- Book value / share
- $6.11
- Price / book
- 0.96
About Nevro Corp
Nevro was a medical device company treating chronic pain in the U.S. and abroad. Its HFX spinal cord stimulation (SCS) platform included the Senza system, which used paresthesia-free 10 kHz therapy for chronic back and leg pain, as well as the Senza II and Senza Omnia systems.
The Senza HFX iQ platform included an implantable pulse generator, a trial stimulator, a patient remote and the HFX App, along with a wireless trial system. HFX AdaptivAI was a pain management platform powering HFX iQ, and the company also sold surgical and percutaneous leads. Sales went through a direct sales force, agents and independent distributors.
Nevro was incorporated in 2006 and based in Redwood City, California. Its shares were delisted from the NYSE in March 2025, with the final trade on March 27, 2025 at $5.84.
- Exchange (former)
- NYSE
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Redwood City, CA
- Employees
- 1,099
- IPO date
- November 6, 2014
- Delisted
- March 27, 2025
- SEC CIK
- 1444380
Nevro financials before the delisting
The last 5 fiscal years Nevro reported as a public company, fiscal year ending December.
NVRO revenue and net income
NVRO earnings per share
NVRO annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2024 | $408.52M | −$113.4M | −$2.17 |
| FY2023 | $425.17M | −$92.2M | −$2.57 |
| FY2022 | $406.37M | $3.0M | −$0.01 |
| FY2021 | $386.90M | −$131.4M | −$3.19 |
| FY2020 | $362.05M | −$83.1M | −$2.49 |
Net income is GAAP. EPS is adjusted (non-GAAP) EPS, as reported.
Nevro stock FAQ
What happened to Nevro stock?
Nevro was delisted from the NYSE in March 2025. The final close was $5.84 on March 27, 2025.
Can I still buy NVRO stock?
No. NVRO is no longer listed on the NYSE or any other U.S. exchange; it was removed on March 27, 2025.
What was the last price of NVRO?
NVRO last closed at $5.84 on March 27, 2025, which valued the company at about $224.09M.
How did Nevro do in its last full fiscal year?
In fiscal 2024, its last full year as a public company, Nevro reported revenue of $408.52M and net income of −$113.4M.
When did Nevro go public?
Nevro shares started trading on November 6, 2014.
NVRO no longer trades, so there is no live quote. The information on this page is for reference only and is not investment advice; see our disclaimer.